![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Preview
Both angioplasty and thrombolytic therapy are successful after myocardial infarction and in general produce similar benefits. Long-term trials comparing the two methods are still under way, but some patients appear to have better results from one method than the other. The authors describe advantages and limitations of the two types of therapy in such patient groups as the elderly and those who have coronary grafts, multivessel disease, or cardiogenic shock.
Additional information
Notes on contributors
Larry R. Handlin
Larry R. Handlin, DO James L. Vacek, MD: Dr Handlin is a fellow in cardiology and Dr Vacek is a clinical professor of medicine, Truman Medical Center, University of Missouri— Kansas City School of Medicine. In addition, Dr Handlin is on staff and Dr Vacek is a cardiologist at Mid-America Heart Institute, St Luke's Hospital, Kansas City.
James L. Vacek
Larry R. Handlin, DO James L. Vacek, MD: Dr Handlin is a fellow in cardiology and Dr Vacek is a clinical professor of medicine, Truman Medical Center, University of Missouri— Kansas City School of Medicine. In addition, Dr Handlin is on staff and Dr Vacek is a cardiologist at Mid-America Heart Institute, St Luke's Hospital, Kansas City.